NDC Code(s) : 0179-0127-50
Packager : KAISER FOUNDATION HOSPITALS
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
Triamterene and HydrochlorothiazideTriamterene and Hydrochlorothiazide TABLET | ||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
PRINCIPAL DISPLAY PANEL
NDC 0179-0127-50
Triamterene and Hydrochlorothiazide Tablets USP
75mg/50mg
50 Tablets Rx only
Each tablet contains:
Triamterene USP, 75 mg
Hydrochlorothiazide USP, 50 mg
Usual Dosage: See insert for full prescribing information.
Dispense in a tight, light-resistant containter wtih a
child-resistant closure.
Store at 20º-25ºC (68º-77ºF). [See USP controlled room
temperature.] Project from light.
Keep this and all medication out of the reach of children.
Manufactured By:
Watson Pharma Private Limited
Verna, Salcette Goa 403 722 INDIA
Code No. GO/DRUGS/741 174377
Distributed By: Watson Pharma, Inc.
Repackaged by:
KAISER FOUNDATION HOSPITALS
Livermore, CA 94551